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Technological advances have made possible the development of high-resolution genetic linkage maps for the mouse. These maps in turn offer exciting prospects for understanding mammalian genome evolution through comparative mapping, for developing mouse models of human disease, and for identifying the function of all genes in the organism.
Historically, the mouse has been the mammal of choice for genetic analysis primarily because of its short gestation period and large litter sizes, the availability of inbred strains, and the ability to perform controlled matings. The mouse has also served as an important model for human genetic diseases such as anemias, autoimmunity and other immune dysfunctions, neurological disorders, birth defects, cancer, diabetes, atherosclerosis, and various reproductive anomalies. In recent years, the development of transgenic and embryonic stem cell technology has made it possible to ectopically express virtually any gene in any mouse tissue and to create targeted germline gain-of-function and loss-of-function mutations. Just in the past year, the ability to introduce into the mouse germ line yeast artificial chromosomes that carry several hundred kilobases of genomic DNA has opened unparalleled opportunities for genome analysis and for the development of new mouse models of human disease. It is not surprising, therefore, that the goals of the Human Genome Project include the development of high-resolution genetic and physical maps of the mouse, leading to the eventual identification and functional characterization of all genes in the organism.
As with human genetic maps, mouse genetic maps serve two distinct goals. First, they provide a tool for genetic analysis and manipulation--including mapping of mutations causing biologically interesting traits, chromosomal localization of cloned genes, and the construction of animals with defined genotypes. Second, they facilitate the development of the physical map, providing a weU-ordered scaffold onto which can be placed "contigs" of overlapping clones.
Gene mapping in the mouse began early in the first part of this century when J. B. S. Haldane, A. D. Sprunt, and N. M. Haldane reported in the Jouma/of Genetics that two coat color mutations, albino and pink-eyed dilution, were linked (1). Conceptually, mouse mapping changed little from the time of Haldane to the early 1970s and consisted primarily of genetic linkage analysis of phenotypic deviants. As a result, the pace of gene mapping proceeded relatively slowly, and the number of mapped loci roughly doubled every decade (2) .
In situ hybridization and somatic cell genetics have been useful in the mouse, but these techniques have played a lesser role in mouse mapping than in human gene mapping. Both techniques rely on the ability to discriminate cytologically between chrom osomes. This is difficult in the mouse because normal mouse chromosomes are all acrocentric (human chromosomes are metacentric) and show a continuous gradation in size. In addition, somatic cell hybrids that carry single mouse chromosomes or chromosomes with deletions or translocations are rare, which complicates subchromosomal gene assignments by this approach. Finally, and probably most importantly, it was usually possible in mice to find a variant that could be genetically mapped with a specific cross, which was not possible in humans.
The explosion in mouse gene mapping in recent years was sparked by the advent of new types of genetic markers. Recombinant DNA techniques allowed the identification and mapping of DNA polymorphisms (3) , which have provided an abundant source of biologically interesting loci for the mouse map. DNA markers were initially scored as restriction fragment length polymorphisms (RFLPs) on Southern (DNA) blots; more recently, many have been developed that can be assayed by the polymerase chain reaction (PCR).
Interspeciflc Crosses
In addition to these new markers, the development of new types of crosses has played a key role in the dramatic explosion in mouse gene mapping. Until the mid1980s, mouse gene assignments tended to rely on two-and three-point crosses between laboratory strains or recombinant inbred strains (4) . However, these approaches are limited by the low degree of allelic variation among laboratory strains. Determining the overall order of genes in the mouse is also problematic if only a handful of genes are informative in any given cross; a composite map can be inferred only indirectly.
These problems were overcome with the use of interspecific crosses, which involve a laboratory strain and a distantly related species of Mus. Interspecific crosses exploit the genetic diversity inherent between wild mouse species and common laboratory strains. Most genes or DNA sequences are polymorphic in an interspecific cross and can thus be placed relative to other genes in a single interspecific cross. DNA from a single cross is suffcient to permit mapping of thousands of genes by RFLPs or tens of thousands of genes by PCR. Because many genes can be mapped simultaneously, gene order is easy to define, at least within a single cross. The use of interspecific crosses for mouse mapping was pioneered by Francois Bonhomme, Philip Avner, and JeanLouis Gunner in the late 1970s and mid1980s (5, 6) . Since that time, many laboratories have developed and made use of interspecific crosses for mouse mapping, and now most mouse genes are mapped in interspecific crosses.
One of the most genetically divergent Mus species that still interbreeds with common laboratory mice to produce at least one sex that is fertile is Mus spretus (6) . For this reason, M. spretus has become the mouse of choice for interspecific crosses. Notwithstanding its advantages, there are two drawbacks to using M. spretus: (i) F1 males are ster/le and thus only female F1 mice can be used as parents in a backcross for gene mapping, which prevents the study of male meiosis; and (ii) the wide divergence between M. sprems and the laboratory mouse may have permitted the accumulation of small chromosomal inversions that could suppress recombination and possibly hamper the fine-structure genetic mapping needed in positional cloning. To overcome these limitations (or at least to hedge their bets), many laboratories have now started also using Mus musculus castaneus or Mus musculus mo/ossinus as the wild mouse parent. These mice are somewhat more closely related to the laboratory mouse, belonging to the same species but a different subspecies. Both sexes are fertile in the F 1 progeny of such intersubspecific crosses. Moreover, the degree of polymorphism in such crosses is very high.
A problem that has not yet been fully resolved is how to combine mapping data generated by different laboratories using different crosses. A partial solution to this problem is to include a common set of anchor loci among the probes mapped in each cross. Mapping data" can then be combined with respect to the anchor loci. Toward this end, the mouse mapping community has defined a common set of anchor loci for use in gene mapping. Anchor loci have been chosen to be evenly spaced every 10 to 20 centimorgans (cM) in the mouse genome, to be highly polymorphic within even intraspecific crosses, to be easily typed by PCR, and to be well mapped in interspecific crosses (7) . Of course, although anchor data provide firm reference points between maps, the order of loci between the anchors can be only indirectly inferred on the basis of distances; such inferences can be unreliable because of variation in recombination frequencies among crosses.
The Mouse Genetic Map
Current genetic maps in mammals are generally composed of four types of loci: mutations that cause phenotypic deviations, isozyme loci, cloned genes, and highly polymorphic anonymous DNA segments. These categories overlap in some cases and will eventually merge as the entire mouse genome is mapped and cloned. Each type of locus plays an important role in genomic analysis. Mutant loci have been mapped throughout the century, and up-to-date maps have been published (7) . Such maps point to biologically interesting genes but alone shed no light on the biochemical basis of the defect. Cloned genes provide important biological information and are especially useful in comparative mapping relating the mouse, human, and •other mammalian genomes. However, gene probes can be tedious to genotype and are often not polymorphic in crosses between closely related strains. Highly polymorphic DNA segments--including minisatellites, microsatellites, and single-strand conformation polymorphisms--provide little biological information, but they are often informative in crosses between closely related strains and many can be rapidly mapped by PCR typing.
The wall chart that appears in this issue represents the integration of two DNA marker'maps: a gene-based map with 1098 loci, which focuses on mouse-human comparative mapping, and a simple sequence length polymorphism (SSLP) or microsatellite map containing 1518 loci. Many genes and anonymous markers mapped in the mouse but not in humans have been omitted from the chart because of space constraints. The map shows many newly reported loci and also presents the first integration of these two mouse maps.
Gene-based map. The framework for the gene-based map is an interspecific backcross map being developed at Frederick, Maryland (8) , which consists of the loci shown in black on the chart. The Frederick map was generated from crosses of (C57BL/6J x M. spretus)F 1 x C57BL/6J mice. Cloned DNA probes were hybridized to Southern blots of DNA from the two parental strains digested with a variety of restriction enzymes to identify RFLPs. The probes were then hybridized to Southern blots of restriction-digested DNAs from the backcrossed mice in order to follow the inheritance of M. spretus-specific RFLP alleles in the progeny. For the construction of the map, the progeny were first typed for a series of markers whose positions had been accurately established on the mouse linkage map in other laboratories. These loci served as anchors for placing new genes on the evolving map. As each additional probe was mapped, the gene order was determined by comparing the new RFLP segregation patterns to the known patterns and finding the .position that minimized the number of crossovers required to explain the new segregation pattern. Because all the loci were mapped in a single backcross, the relative position of each of these loci was established with a high degree of confidence. (7) . A few DNA segments, particularly those mapping in the proximal region of mouse chromo~ some 17, were omitted from the chart because of space constraints. The loci reported in ,the committee reports were mapped by many different laboratories using a variety of different techniques (7) . Because these loci were mapped in many different crosses, the position of these loci on the Frederick framework map can b e only indirectly inferred from available mapping information. The locations of these loci on the map should thus be considered provisional.
The Frederick framework map shown in the chart has been aligned with respect to the centromere by mapping various proximal loci (indicated by brackets) in a separate interspecific cross in which the inheritance pattern of cytologically visible subeentromeric repeats had been established (9) . Because the mapping was performed in a separate cross, the distances are not perfectly comparable and, for a few chromosomes, some appear to extend 1 to 3 cM beyond the centromere. When telomere probes are developed, it will be possible to define the complete extent of the genetic map.
SSLP map. The SSLP map consists of polymorphic genetic markers defined by PCR assays, each involving a specific pair of primers flanking the site of a di-, tri-or tetranucleotide repeat sequence having a variable length in differing mouse strains. SSLPs or microsatellite polymorphisms were first described by Weber and May (10) in humans and were first studied by Todd and colleagues (11) The SSLPs were all genotyped in a single (C57BL/6J-ob x CAST/Ei)F2 intersubspecific cross (CAST/El is a strain of M. m. castaneus). The genetic map was built by analyzing the inheritance patterns with the MAPMAKER computer program (13) ; for this, those SSLPs taken from genes with known chromosomal position served as anchors for alignment with the previous mouse maps. Because all the loci were analyzed in a single cross, their relative positions were established with a high degree of confidence. The gene orders are supported by a likelihood ratio of 1000:1, except for underlined loci whose position is less well established. These underlined loci represent markers for which there is not full genotypic information. The data were subjected to a mathematical error-checking procedure (14) to identify likely typing errors and have been extensively rechecked. Because the mapping cross involved only about 100 meioses, markers are clustered in "bins" whenever no crossovers occurred in the meioses studied; the fine-structure order of these markers can be established by studying more meioses or by physical mapping. The spacing between markers is reasonably close to random, although mathematical tests can detect a small but statistically significant excess of larger intervals that may correspond to recombinational hotspots.
The SSLP map in the chart showing 1518 loci was current as of 1 July 1993." As this article goes to press, the total number of SSLP loci is already more than 2000. Taking advantage of the ability to distribute SSLPs simply• by publishing their sequence, WI/MIT-CGR maintains an electronic mail (e-mail) server to provide up-to-date information about the map, including the locations, primer sequences, and allele sizes of all SSLPs. In addition, GenBank names for SSLP markers taken from GenBank are available via the e-mail server. To obtain an e-mail query form and instructions, send an e-mail n~essage with the single word help to genome_database@genome.wi.mit.edu.
Integration and comparison of maps. The
two maps play complementary roles in mouse genetics: the SSLP map provides markers•now routinely used for the genetic analysis of crosses, whereas the gene-based map shows the known genes in a region, thereby suggesting likely candidate genes for a mutation and indicating correspondence to the human genome. With the aim of merging this information into a single comprehensive view of the mouse genome, the Frederick and Whitehead groups recently undertook a project to integrate the two maps. In order to do so, 254 of the SSLPs developed at WI/MIT-CGR were genotyped in a subset of 46 progeny from the Frederick interspecific backcross. SSLP markers that were relatively well spaced throughout the mouse genome were chosen for the integration. On the basis of their inheritance patterns, the SSLPs could be assigned to intervals in the Frederick map that were defined by the closest flanking crossovers in the progeny scored--typically, a region of about 2 cM. Although this does not establish fine-structure local order, it establishes 254 ties between the two maps (shown by green lines connecting the SSLP map with the chromosome diagram in the c e n t e r ) -roughly one SSLP marker every 6 cM.
It is interesting to compare certain features of the maps, such as genetic length. The genetic length of the mouse genome has been estimated to be about 1600 cM, and the chromosome lengt~ in the chart are drawn to scale on the basis of this estimate. However, the frequency of recombination between loci is not constant but may depend on the cross and the sex Of the individual in which meiosis occurs (15) . Overall, although not thoroughly examined for mice, recombination distances appear larger in female than male meiosis, but for some chromosomal regions male recombination distances are greater (•6).
In the Frederick cross, the total genetic length is estimated to be only about 1350 cM. Given the large number of markers on the map, the Frederick map would be expected to cover nearly the entire genome. Yet, each chromosome appears shorter than predicted, with the exception of chromo-SCIENCE • VOL. 262 ° 1 C)CTOBER 1993 some 11. The discrepancy may be even greater than it seems because genetic distance was measured only in female meiosis, which shows more recombination as a rule. It is possible that small inversions and other rearrangements between C57BL/6J and M. spretus chromosomes may suppress recombination and result in a smaller map, although only one instance of a structural difference has been documented so far, a small inversion in the proximal region of M. spretus chromosome 17 (17) . In the SSLP map, the genetic length is somewhat larger, although still less than 1600 cM. The total length is estimated to be about 1450 cM, with genetic distances in this cross representing the average of male and female meiosis in an intersubspecific cross. There may also be some recombinational suppression in this cross as well. Alternatively, it may be that the conventional estimate of 1600 cM is simply !0% too high.
Closer comparison suggests possible regions of recombinational suppression. One clear example is the interval from D5Mitl9 to D5Mit68, which measured 24 cM in the SSLP cross but was compressed to only 6 cM in the Frederick cross; this would be consistent with the occurrence of a small inversion within this interval in M. spretus compared to C57BL/6J and •CAST/EL More thorough examination of recombinational suppression will require typing markers in various interspecific, intersubspecific, and intraspecific crosses. Fluorescence in situ hybridization may then prove useful in confirming candidate inversions.
Transmission ratio distortion, the occurrence of non-Mendelian ratios for some loci, is often observed in interspecific crosses in animals and plants. In the mouse, it was first reported in a (C3H/HeHa × M.
spretus)Fl × M. spretus backcross in which
there was a deficiency of backcross males carrying the intact :X chromosome from C3H/HeHa (•8). The mechanism (or mechanisms) responsible for transmission ratio distortion are not understood but may result from differential embryo survival because of different combinations of progenitor strain alleles. In the Frederick (C57BL/ 6J × M. spretus) interspecific backcross, transmission ratio distortion was observed for chromosomes 2, 4, and 10 (19), with the distortion consistently involving an excess of M. spretus alleles relative to C57BL/ 6J alleles inherited by backcross mice: By contrast, the (C57BL/6J x CAST/El) intersubspecifiC intercross showed no statistically significant evidence of transmission distortion. It is not clear whether this difference reflects greater incompatibility between C57BL/6J and M. spretus alleles, but the mapping and cloning of the loci that cause the transmission ratio distortion seem feasible.
Appl#cations of the Map
Mouse maps, such as those depicted on the chart, have many different applications for genome research. Although their uses are too numerous to outline here, we highlight here some of the more important applications of the maps for current and future genome research.
Comparative mapping. Of the 2616 loci listed in the chart, 917 have homologs that ° have been mapped in humans (Table 1) .
These loci mark 101 segments of conserved linkage homology. On the chart, these conserved linkages are shown as colored segments within each chromosome map, and a summary of these results is shown in Fig. 1 . The total length of all conserved autosomal segments is 911 cM, which indicates that -6 1 % of the genome is already accounted for in the current comparative map. Correcting for the fact that these conserved segments extend some distance beyond their current bounds (20), we estimate that approximately 1194 cM, or 80% of the mouse autosomal genome, is accounted for in the comparative map. In 1984, Nadeau and Taylor calculated that the average length of a conserved autosomal segment in mice is -8.1 cM (20) .
This calculation was based on 83 homologous loci marking 13 conserved segments and on several assumptions concerning the distribution of recombination and rearrangement breakpoints. By applying the same calculation to the map shown in the chart, which represents roughly a -15-fold increase in data, the current average length of a conserved autosomal segment is 8.8 cM, which is not statistically different from the previous estimate. This remarkable consistency strongly suggests that the assumptions that underlie the calculation are correct.
Several examples exist of linkage conservation across a human centromeremfor example, the region of human chromosome 20 homology on mouse chromosome 2 and the region of human chromosome 17 homology on mouse chromosome 11. Whether these represent ancestral linkages or derived rearraiigements remains to be determined through more detailed comparative mapping studies.
The large number of conserved segments shown in the current map suggest that multiple chromosomal rearrangements have occurred since the divergence of the lineages leading to humans and mice. On the basis of the data in the chart, we calculate that approximately 150 rearrangements have occurred since this divergence (20) .
These rearrangements likely have occurred through several different mechanisms, inchding chromosome translocations, inversions, insertions, and other complex rearrangements. Such rearrangements have even led to changes in gene order within conserved segments (Table 1 ).
An important application of the comparative map is the transfer of linkage information and genome resources from "map-rich" to "map-poor" species (2 I, 22) .
By mapping a well-defined set of evolutionarily conserved loci across mammalian genomes, it should be possible to use these conserved loci as reference points to transfer linkage information from "map-rich" species such as humans and mice to "mappoor" species such as cow, pig, and sheep and thereby expedite genome research. This is somewhat analogous to using anchor loci to combine linkage data within a single species. Such a set of reference loci for comparative mapping in mammals was recently proposed (22) .
Another important application of the comparative map involves analysis of complex traits. Susceptibility to many important genetic disorders is controlled by more than one gene, and the identification of these genes is often easier in mice than in humans. Once a candidate disease gene or disease region is identified in the mouse, the homologous genes or regions in humans can be screened to see if they are linked to the corresponding human genetic disease.
Genome evolution and the origin of multigene families. Multigene families are thought
to be generated by a number of different mechanisms. These include (i) reverse transcription, a process likely responsible for pseudogene formation; (ii) tandem gene duplication, which is thought to arise from unequal crossing-over; and (iii) genome duplication. Genome duplication could involve chromosomal segment duplication, chromosome duplication, or whole genome duplication. It is believed that the eukaryotic genome has undergone multiple g enome duplication events, with the most recent duplication event occurring approximately 300 million years ago, long before the divergen£e of the lineages leading to the mouse and human genomes (23) . As more and more multigene families are mapped in themouse as well as other mammalian species, it should be possible to begin to piece together the nature of the events giving rise to multigene families. Like traditional comparative maps, maps of duplicated or paralog0us chromosomal segments can also be used to predict linkages and identify candidate disease genes.
A recent example of the power of the mapping approach for the study of the evolution of mammalian multigene families can be found in Wilkie et al. (24) , who studied the evolution of the mammalian Ga protein subunit multigene family. In this study, Wilkie and co-workers showed that members of two of the four subclasses, ping can be found in the evolution of the homeobox genes (25) . Mapping can also provide unexpected insights into chromosome evolution. For example, although the X chromosome tends to show extreme conservation of genes • across mammalian species, Disteche et al. (26) recently showed that the mouse granulocyte-macrophage colony-stimulating factor receptor ct subunit gene (Csfgtara), which is located in the pseudoautosomal region of the X and Y chromosomes in humans, maps to the very distal region of mouse chromosome 19. This was the first demonstration of a gene that is pseudoautosomal in humans but not in mice. This finding may not be surprising, however, because it is known that genes in the pseudoautosomal region have homologs on both the X and Y chromosomes and are likely to escape X inactivation (26) ; the process of X inactivation is thought to be responsible for the conservation of genes on the mammalian X chromosome.
Cloning classical mouse mutations. Over the past century, hundreds of mutations that cause deviant phenotypes have been identified and characterized in the mouse. These mutations represent spontaneous mutations, as well as mutations induced by chemicals, radiation, transgene insertion, viral integration, and more recently, homologous recombination in embryonic stem (ES) cells. Although it is obvious that many of these mutations define a set of developmentally importaht genes, few of the mutant genes have been cloned, with the exception of those mutations induced by homologous recombination in ES cells.
Mouse linkage maps are already having a great impact on the rate at which these mutations are cloned. In Table 2 , we have compiled a list (albeit probably incomplete) of mouse mutations that have been successfully cloned. Most of these mutations (31 of 42) were cloned by the candidate gene approach, which works as follows: As each new gene is placed on the mouse map, phenotypic deviants mapping in the vicinity can be reviewed to determine ff any has a phenotype consistent with what one might expect to result from a defect in the mapped gene. If a plausible connection is found, the gene in question can be molecularly characterized in both wild-type and deviant mice for the identification of mutations. Given the rapid expansion of the gene-based map, it is likely that many more mutations will be cloned in the future by means of the candidate gene approach.
Several mouse mutations (5 of 42) were cloned after one or more alleles were found that are molecularly tagged with a transgene insertion, viral sequence, or genome rearrangement (Table 2) . Again, one of the first steps in this cloning approach is to map sequences from the tagged allele in order to determine if any mutations exist that map in the same vicinity and that have a phenotype similar to that of the molecularly tagged allele. Complementation tests for recessive and semidominant deviants can then be performed to determine ff the molecularly tagged allele is allelic with any preexisting mutations. The molecular tag can then be used as an entry point for cloning the mutated gene.
Several other mutations have been cloned by positional cloning (4 of 42)--that is, chromosomal walking from nearby genetic markers (Table 2 ) (27) . Until very recently, this approach was largely impractical because of the paucity of molecular markers on the mouse genetic map and the absence of efficient walking methods and large insert libraries. However, given the great increase in marker density on current mouse genetic maps, particularly with respect to SSLP markers, and given the availability of large-insert yeast artificial chromosome (YAC) libraries of the mouse genome (28) , it is now possible to positionally clone virtually any mouse mutation. The rate-limiting steps in positional cloning have now become the generation of large numbers of backcrossed animals needed to define recombination events in close proximity to the mutation of interest and the identification and evaluation of candidate genes in the nonrecombinant interval, rather than the identification of closely linked markers. As physical maps of the mouse genome become available and techniques for identifying genes in large blocks of genomic DNA improve, the ability to clone mutations On the basis of their position will be enhanced.
Two classical spontaneous mutations were cloned serendipitously as an indirect result of attempts to generate germ-line knock-out mutations in the transforming growth factor a (Tgfa) and wingless-related mouse mammary tumor virus (MMTV) integration site-1 (Wnt:l) genes. Knock-out mutations in these two genes produced phenotypes very similar to those of the spontaneous mutations waved-1 (wa-1) and swaying (sw), respectively. Complementation tests showed that the classical mutations were allelic to the knock-out mutations, and molecular studies confirmed that the spontaneous mutations resulted from defects in these genes. Given the rapid rate at which new genes are being knocked-out by homologous recombination, it is likely that other classical mutations will be cloned by this approach as well. Again, maps and phenotypic comparisons will continue to provide the crucial clues.
Mouse models of human genetic diseases.
The mouse has provided many important models of human genetic diseases. In the chart, we have provided a partial list of known single-gene models of human genetic diseases as well as polygenic disorders that may also be models for certain human conditions. Even with such a partial list, it is obvious that the number of known or SCIENCE * VOL. 262 ° 1 OCTOBER 1993potential mouse models of human diseases is large and includes some of the most important diseases affecting humans. Not included in this list are many uncloned mouse mutations that are also thought to represent models for human diseases (29) . As discussed earlier, the development of a high-density linkage map of the mouse genome will greatly increase the speed at which these mutations are cloned and hence facilitate the development of additional models of human diseases. Once human disease genes are cloned and mutations characterized, further research on gene fimction and disease will rely in part on mouse models.
Mapping genes in the mouse can also facilitate the cloning of human genetic disease loci, even in cases where no appropriate mouse model exists. For example, given the speed at which new genes can be mapped in the mouse, the high density of the mouse linkage map, and the considerable amount of information already gained regarding human-mouse comparative mapping, it is often easier to map a new gene in the mouse and predict its location in humans than to map the gene directly in humans. In some cases, the predicted location may lie near an already mapped human disease locus and subsequent studies may show that defects in that gene are in fact responsible for the disease (30). Mice offer great advantages for LOH mapping compared to humans. F 1 hybrid mice between two strains can provide an unlimited number of tumors from a genetically defined background that can all be typed with a single set of fully informative markers. The use of F, hybrids eliminates the effect of genetic background; this is unlike the situation in human studies, where one cannot typically tell whether variation in LOH among patients is due to chance or inherited differences affecting the process of tumorigenesis. In mice, one can also study whether one allele is preferentially lost in the Fi hybrids, which suggests that the opposite chromosome carries a linked locus predisposing to cancer; such assessments are impossible in outbred populations such as that of humans. Moreover, in mice tumor progression can be analyzed by examining tumors at various histological stages. Finally, fine-structure deletion mapping and positional cloning of tumor suppressor genes in mice should be feasible, given the ability to collect hundreds of tumors. With a wide range of naturally occurring, chemically induced, and transgene-induced tumors available, the mouse is ideal for genetic studies of tumorigenesis in vivo.
Physical maps, gene catalogs, and genomic sequences. Over the next decade, mouse genome mapping will continue at a rapid pace. One early target will surely be construction of a complete physical map of the mouse genome. Although the mouse genome is the same size as the human genome; the task of physical mapping is simplified by the ease of Ordering anchor points by genetic mapping. Indeed, a physical map should virtually fall out as the density of markers in the genetic map increases. The current genetic map with 1500 SSLPs has an average spacing between markers of about 2 Mb, which corresponds to about three, large-insert (-700 kb) YACs from available libraries (28) . With projects under way to create a map of 6000 SSLPs, the average spacing should fall to about 500 kb, with the result that most of the physical map may be constructed simply by identifying the YACs corresponding to each consecutive marker along a chromosome (37) .
A subsequent milestone will be the identification of all mouse genes and their localization on the genetic and physical maps. With improved methods fo r generating "normalized" complementary DNA (cDNA) libraries, it may become practical to catalog genes from all developmental stages and most adult organs by complete cDNA sequencing and PCR-based mapping of the cDNAs to YACs. A natural extension of today's gene-based map, such a catalog should prove invaluable for studies involving positional cloning, human-mouse comparison, and genome organization.
Finally, the recently revised goals of the Human Genome Project include obtaining" the complete nucleotide sequences of both the human and mouse genomes. By companng two mammalian genomes, important regions should become obvious by virtue of their sequence conservation over 140 million years of evolution. Already, comparative sequencing of the T cell receptor regions in humans and mice has revealed many novel regulatory signals (38) . Although the notion of sequencing two mammalian genomes might seem prohibitively costly, it seems likely that DNA sequencing technology either will advance to the point that both genomes can be easily sequenced or will fall short of accommodating even a single genome; it is implausible that it will be feasible to sequence one but not both.
Conclusion
Mouse genetics began several hundred years ago, with the cultivation of coat color and neurological mutants whose odd colors and behaviors entertained the imperial courts of Japan (39) . Over the past half century, the mouse has become a mainstay of biomedical research in areas ranging from embryology to immunology. As mouse genetics enters the next millenium, it is clear that the field will continue to provide an ever deeper window into ourselves through the many similarities in our physiology, our heritable diseases, and, ultimately, our genomes.
